- Home
- Companies
- micronesia
- cell carcinoma
Refine by
Cell Carcinoma Suppliers Near Micronesia
42 companies found
based inAmadora, PORTUGAL
Medinfar group is a Portuguese pharmaceutical company, founded in 1970. It is a leading company in Portugal in the Consumer Health and Dermatology sectors and is the third largest company in Portugal. Today more than ever, we can say that this is a ...
Actinic Keratosis is a very common skin disease characterized by superficial lesions, which appear on skin that has been exposed to the sun. (1);(2). Actinic Keratosis are deemed pre-cancerous lesions because they can evolve into squamous ...
based inFriendswood, TEXAS (USA)
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and ...
Predicting Individual Risk of Metastasis: DecisionDx-SCC is now commercially available. DecisionDx-SCC is clinically validated as a significant predictor of metastasis and the strongest predictor of risk compared to traditional clinical and ...
based inOlathe, KANSAS (USA)
TVAX Biomedical is a clinical stage development company advancing its novel targeted cell-based immunotherapy for the treatment of cancer. TVAX Biomedical is developing a paradigm-shifting cancer treatment that offers the promise of improved ...
TVAX®’s second candidate (TVI-Kidney-1) is being evaluated for the treatment of kidney cancer and targets stage 4 renal cell ...
based inPittsburgh, PENNSYLVANIA (USA)
Lipella is a privately-held biotechnology company with a focus on supportive care to cancer survivors who acquire hemorrhagic cystitis, also called radiation cystitis, when hemorrhagic cystitis occurs after pelvic radiation, as well as improved ...
based inBoston, MASSACHUSETTS (USA)
AVEO is an oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for cancer patients. AVEO™s strategy is to focus its resources toward development and commercialization of its product candidates in ...
Ficlatuzumab (formerly known as AV-299) is a potent hepatocyte growth factor (HGF) immunoglobulin G1 (IgG1) inhibitory antibody that binds to the HGF ligand with high affinity and specificity. HGF is the natural ligand of c-Met and blocking HGF ...
based inNorcross, GEORGIA (US) (USA)
Xstrahl is a prominent global provider specializing in the development and delivery of superficial radiation therapy devices and advanced preclinical radiation research systems. The company is actively engaged in connecting experts to further the ...
The Xstrahl 100 is a specialized low-energy X-ray system designed to provide accurate treatment for superficial skin conditions, including non-melanoma skin cancers like basal cell and squamous cell ...
based inHERFORD, GERMANY
For over 50 years MEDlight has applied its industry leading experience in medical light technology to innovative treatment solutions. Our broad product portfolio is unmatched in scope and quality. This enables us to cover the needs for a great ...
Painfree Compact Daylight PDT; Enhanced conventional PDT; Large adjustable treament area; New touchscreen with many features; Highly flexible and adjustable device arm; Premium design with durable high quality ...
based inDurham, NORTH CAROLINA (USA)
GeneCentric Therapeutics is applying our proprietary rT(I)ME Explorer Platform to identify high resolution molecular subtypes and drug responder populations that enable the development of precision cancer drugs while improving patient outcomes. Our ...
Pancreatic Cancer is the 11th most common cancer type with an estimated 55,000 new cases in the US in 2018, according to the United States National Cancer Institute. While it represents three percent of all cancers, pancreatic cancer is one of the ...
based inCoralville, IOWA (USA)
In April 2018, Digital Diagnostics(formerly known as IDx) became the first company to ever receive FDA clearance for an AI diagnostic platform that makes a diagnosis without physician input at the point-of-care. This achievement did not happen ...
Our autonomous AI research expands the reach of dermatological care beyond the exam room, from skin cancer to inflammatory disease. We are currently recruiting pilot locations and research groups interested in skin diagnostics and ...
based inNewtown, PENNSYLVANIA (USA)
Formely known as Onconova Therapeutics, Inc. Traws Pharma is a clinical stage biopharmaceutical company developing small molecule oral product candidates for respiratory viral diseases and cancer. In the viral respiratory disease space, Traws Pharma ...
Rigosertib is a small molecule that inhibits multiple cellular signaling pathways driving cancer cell growth while having little effect on normal cells. In contrast to many kinase inhibitors, rigosertib does not interact at the ATP binding site, but ...
based inJiangmen City, CHINA
OBS commits to the researching and manufacturing on clinical medical equipments, and has a wide product range including electrosurgical generator, electrosurgical smoke evacuation system, electrosurgical pencil, various electrosurgical electrodes, ...
Unique dual radio frequency design. Combine 4Mhz and 1.7Mhz into one generator. Realize the best operation result effectively. Suitable for Plastic, Dermatology, ENT, Ophthalmology, Dentistry, Podiatry and Spinal surgery ...
based inWayne, PENNSYLVANIA (USA)
Palvella Therapeutics was founded to serve individuals suffering from rare diseases by developing safe and efficacious therapies that will dramatically enhance their quality of life. We focus on developing therapies that specifically target the root ...
QTORIN™ rapamycin 3.9%is a novel targeted topical therapy being studied for Gorlin syndrome. Palvella is enrolling a phase 2b clinical study (CODY) for people with Gorlin ...
based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
The Modi-2 vaccine exploits a second post-translational modification, stimulating the production of CD4 T cells using tumour-associated peptide epitopes in which the lysine residues are converted to homocitrulline. This change occurs via a process ...
based inBrunswick, AUSTRALIA
Avania is an integrated global, full-service CRO with specialized expertise in medical device, novel technology, and combination products. They advance products from feasibility all the way through post-approval trials in analytics, clinical trials, ...
Although skin is the largest organ of the human body, it takes a team with specialized knowledge to successfully advance dermatology trials. We collaborate with you to ensure your dermatology trial starts on the right track, delving into the details ...
based inJacksonville, FLORIDA (USA)
EDM3 Solutions was formed in October 2019 by three healthcare executives with over 85 years of experience in the industry with the #1 goal of providing the best customer service in healthcare. That same month, these premium quality product lines ...
Tissue staining is the cornerstone of Mohs Micrographic Surgery (MMS). EDM3s new “all inclusive” Mohs Lab Staining Kit, will consistently yield slides with the highest quality, excellent morphology and differentiation of target cellular ...
based inBellevue, WASHINGTON (USA)
EMulate Therapeutics is a clinical-stage therapeutic device company utilizing its patented proprietary radio frequency energy (RFE) technology, targeted at the low and ultra-low ends of the RFE spectrum (ulRFE®), to provide safe and effective ...
Cellsana is pivotal (phase III) trial ready for treatment of Glioblastoma (GBM) and Diffuse Midline Glioma ...
based inModena, ITALY
Holostem Terapie Avanzate is the first biotechnological company entirely devoted to development, manufacture, registration and distribution of Advanced Therapies Medicinal Products (ATMPs) based on cultures of epithelial stem cells both for cell and ...
Epidermolysis Bullosa (EB) is a group of genetic adhesion disorders characterized by fragility of the skin. EB are devastating, highly disfiguring, blistering pathologies that severely impairs the quality of life of patients and affect approximately ...
based inNewark, DELAWARE (USA)
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across ...
IL-15,Interleukin-15,IL15,Interleukin ...
based inBarcelona, SPAIN
INTERmedic is a dynamic company that is still expanding, after more than 25 years in the medical technology business sector. INTERmedic develops, manufactures and distributes innovative medical systems, based on the most advanced laser technology ...
INTERmedic, worldwide leader in photodynamic therapy for pulmonology (lung cancer), gastroenterology (Barrett’s esophagus, esophageal cancer), urology (prostate cancer) among others, presents Multidiode™ PDT, an innovative technology to ...
based inMountain View, CALIFORNIA (USA)
Osel’s mission is to develop and commercialize a broad portfolio of Live Biotherapeutic Products (LBPs) that prevent or treat abnormal conditions resulting from a disruption of the human microbiome. In 2003, Osel was one of the first companies to ...
CBM588 is an orally-administered Clostridium butyricum strain with a long history of clinical use and safety in all age groups in Japan. In Japan, CBM588 has primarily been used to treat infectious and noninfectious diarrheal disorders associated ...